At present, few studies have suggested the prognostic importance of TICs and other immune molecules, including tumor-associated macrophages, natural killer cells, dendritic cells, TIM-3, PD-L1, and PD-L2 in HCC patients (29–32). This evidence concerns the gene PDCD1LG2 and neoplasm.